SCI Pharmtech (Taiwan) Market Value
4119 Stock | TWD 95.50 2.10 2.15% |
Symbol | SCI |
SCI Pharmtech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SCI Pharmtech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SCI Pharmtech.
12/03/2023 |
| 11/27/2024 |
If you would invest 0.00 in SCI Pharmtech on December 3, 2023 and sell it all today you would earn a total of 0.00 from holding SCI Pharmtech or generate 0.0% return on investment in SCI Pharmtech over 360 days. SCI Pharmtech is related to or competes with Grape King, Standard Chemical, Adimmune Corp, ScinoPharm Taiwan, and Excelsior Medical. SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and specialty chemic... More
SCI Pharmtech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SCI Pharmtech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SCI Pharmtech upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 0.7918 | |||
Information Ratio | (0.01) | |||
Maximum Drawdown | 5.36 | |||
Value At Risk | (0.67) | |||
Potential Upside | 1.34 |
SCI Pharmtech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SCI Pharmtech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SCI Pharmtech's standard deviation. In reality, there are many statistical measures that can use SCI Pharmtech historical prices to predict the future SCI Pharmtech's volatility.Risk Adjusted Performance | 0.1218 | |||
Jensen Alpha | 0.1223 | |||
Total Risk Alpha | (0.01) | |||
Sortino Ratio | (0.01) | |||
Treynor Ratio | (1.64) |
SCI Pharmtech Backtested Returns
At this stage we consider SCI Stock to be very steady. SCI Pharmtech owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the company had a 0.16% return per unit of volatility over the last 3 months. We have found thirty technical indicators for SCI Pharmtech, which you can use to evaluate the volatility of the entity. Please validate SCI Pharmtech's Downside Deviation of 0.7918, market risk adjusted performance of (1.63), and Risk Adjusted Performance of 0.1218 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. SCI Pharmtech has a performance score of 12 on a scale of 0 to 100. The firm has a beta of -0.0696, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning SCI Pharmtech are expected to decrease at a much lower rate. During the bear market, SCI Pharmtech is likely to outperform the market. SCI Pharmtech now has a risk of 0.78%. Please validate SCI Pharmtech downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if SCI Pharmtech will be following its existing price patterns.
Auto-correlation | 0.38 |
Below average predictability
SCI Pharmtech has below average predictability. Overlapping area represents the amount of predictability between SCI Pharmtech time series from 3rd of December 2023 to 31st of May 2024 and 31st of May 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SCI Pharmtech price movement. The serial correlation of 0.38 indicates that just about 38.0% of current SCI Pharmtech price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.38 | |
Spearman Rank Test | -0.01 | |
Residual Average | 0.0 | |
Price Variance | 3.26 |
SCI Pharmtech lagged returns against current returns
Autocorrelation, which is SCI Pharmtech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SCI Pharmtech's stock expected returns. We can calculate the autocorrelation of SCI Pharmtech returns to help us make a trade decision. For example, suppose you find that SCI Pharmtech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
SCI Pharmtech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SCI Pharmtech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SCI Pharmtech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SCI Pharmtech stock over time.
Current vs Lagged Prices |
Timeline |
SCI Pharmtech Lagged Returns
When evaluating SCI Pharmtech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SCI Pharmtech stock have on its future price. SCI Pharmtech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SCI Pharmtech autocorrelation shows the relationship between SCI Pharmtech stock current value and its past values and can show if there is a momentum factor associated with investing in SCI Pharmtech.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SCI Stock Analysis
When running SCI Pharmtech's price analysis, check to measure SCI Pharmtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCI Pharmtech is operating at the current time. Most of SCI Pharmtech's value examination focuses on studying past and present price action to predict the probability of SCI Pharmtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCI Pharmtech's price. Additionally, you may evaluate how the addition of SCI Pharmtech to your portfolios can decrease your overall portfolio volatility.